How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
20 articles on this topic
-
How Long Does Semaglutide Stay in Your System?
Injectable semaglutide has an elimination half-life of about one week and can remain in circulation for roughly five to seven weeks after the last dose. Its effects fade on a curve, not at a single cutoff.
-
Is Tirzepatide a Peptide? A Clear Answer
Yes. Tirzepatide is a 39-amino-acid synthetic peptide, and it is also a dual GIP/GLP-1 receptor agonist. Those labels describe its structure and its action, respectively.
-
DSIP Dosage: What the Human Studies Used
There is no standard clinical dose for delta sleep-inducing peptide. The small human studies used intravenous infusions under observation, not a validated at-home schedule.
-
How Does Semaglutide Work? Four Effects Explained
Semaglutide activates one receptor but produces coordinated signals in the pancreas, stomach and brain. Its engineered C18 side chain keeps those signals available for about a week.
-
How Does Tirzepatide Work? The Dual Mechanism
Tirzepatide activates two nutrient-sensitive hormone receptors, not one. The result is a linked set of effects on insulin, glucagon, stomach emptying and the signals that shape hunger and fullness.
-
Sermorelin Benefits: What the Trials Found
In the best controlled study of GHRH in older adults, nocturnal growth hormone rose, IGF-1 climbed within two weeks, skin thickened — and lean body mass increased in men only. The specificity is the point.
-
Ipamorelin Benefits, Side Effects, Legal Status
Developed at Novo Nordisk in the late 1990s, ipamorelin is a five-amino-acid peptide that released growth hormone in animal studies without raising cortisol even at more than 200 times its effective dose.
-
Retatrutide and the Rise of the Triple Agonist
In its 48-week phase-2 obesity trial, retatrutide's highest dose produced an average 24.2% body-weight reduction — at publication, the largest average weight loss any obesity drug trial had reported.
-
Epitalon Benefits, Sorted by Evidence Tier
The most-cited animal experiment gave 54 mice per group monthly doses for life and found mean lifespan unchanged, maximum lifespan up 12.3%, and leukemia down six-fold.
-
Oxytocin Peptide Beyond the 'Love Hormone'
A 2025 meta-analysis pooling 20 effect estimates from 13 human studies found no overall effect of oxytocin on non-social executive function — one number that explains why this molecule's science reads nothing like its nickname.
-
The Thymulin Peptide Needs Zinc to Work
Thymulin is inert until a zinc ion binds it at a 1:1 molar ratio — and every published result in its literature comes from mice, rats, or cell culture.
-
KPV Peptide and the Gut Inflammation Evidence
KPV is the C-terminal tripeptide of alpha-MSH, and in mice whose MC1R does not function, every animal in the KPV-treated group survived DSS colitis — a result that points away from melanocortin receptors entirely.
-
SS-31 Peptide: A Patient's Guide to Elamipretide
SS-31 and elamipretide are two names for the same four-amino-acid peptide, and its branded injectable form received accelerated approval from the FDA on September 19, 2025 for a single ultra-rare genetic disease.
-
What Does Tesamorelin Do?
In 26-week Phase 3 trials, daily tesamorelin reduced visceral abdominal fat by 10.9–15.4% in adults with HIV-associated lipodystrophy while placebo groups gained fat.
-
CJC-1295 and Ipamorelin: Why They're Paired
One prescription, two receptors: CJC-1295 signals through the GHRH receptor while ipamorelin mimics ghrelin at GHSR-1a — two separate inputs to the same growth-hormone axis.
-
How Does PT-141 Work? Brain, Not Blood Vessels
PT-141 initiates the arousal signal at melanocortin receptors in the hypothalamus rather than in blood vessels — a mechanism tested in 1,267 premenopausal women across two Phase 3 trials.
-
Thymosin Alpha 1 Peptide: The Trial Record
Thymalfasin — the drug form of the thymosin alpha 1 peptide — is approved in over 30 countries, and the largest trial ever run on it, in 1,106 sepsis patients, returned a 28-day mortality hazard ratio of 0.97.
-
MOTS-c Peptide Benefits: Rodent Depth, Human Hints
MOTS-c is a peptide your mitochondria encode themselves — and it is studied for how cells handle fuel. The rodent evidence runs deep; the human evidence is just beginning.
-
The DSIP Peptide: A 1970s Sleep Mystery
The DSIP peptide was isolated from the blood of sleeping rabbits in 1970s Switzerland, yet no one has ever found its receptor — or the gene that would prove mammals make it.
-
What Does Kisspeptin Do? The Signal Above GnRH
Kisspeptin sits one rung above GnRH in the reproductive axis, and the ~4-minute half-life routinely quoted for kisspeptin-10 — the form Promise dispenses — was measured in mice, not people.